Blood Pressure and OXygenation Targets After OHCA

NACompletedINTERVENTIONAL
Enrollment

802

Participants

Timeline

Start Date

March 10, 2017

Primary Completion Date

December 15, 2021

Study Completion Date

March 15, 2022

Conditions
Out-of-Hospital Cardiac ArrestBlood PressureHemodynamic Instability
Interventions
OTHER

Low normal MAP

The patients are randomized to recieve a Phillips M1006B blood pressure measuring module, offset by +10 %. All patients will target a MAP of 70, but due to the offset module, the patients will target an actual blood pressure of 63 mmHg.

OTHER

High normal MAP

The patients are randomized to recieve a Phillips M1006B blood pressure measuring module, offset by -10 %. All patients will target a MAP of 70, but due to the offset module, the patients will target an actual blood pressure of 77mmHg.

OTHER

Low normal PaO2.

The patients are randomized to a PaO2 target of 9-10 kPa (open-label).

OTHER

High normal PaO2

The patients are randomized to a PaO2 target of 13-14 kPa (open-label).

Trial Locations (2)

2100

Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen

5000

Depart med Cardiothoracic Intensive Care, Odense University Hospital, Odense

All Listed Sponsors
collaborator

Odense University Hospital

OTHER

lead

Jesper Kjaergaard

OTHER

NCT03141099 - Blood Pressure and OXygenation Targets After OHCA | Biotech Hunter | Biotech Hunter